Table 4.
Adjusted Absolute Differences in Performance Rates Between US Hispanic and Puerto Rican Hispanic MA Enrollees
| Characteristic | Absolute Difference, Adjusted (95% CI), Percentage Points | |
|---|---|---|
| Adjusted for Age and Sex | Adjusted for Age, Sex, and Poverty | |
| Comprehensive diabetes mellitus care | ||
| Annual HbA1c testing (n = 29 322) | −7.7 (−9.6 to −5.8) | −5.6 (−7.7 to −3.5) |
| HbA1c >9% (n = 29 299) | 20.2 (10.3 to 30.2) | 10.4 (−0.4 to 21.1) |
| Retinal eye examination (n = 29 103) | −11.6 (−17.5 to −5.7) | −7.8 (−15.9 to −0.4) |
| Annual LDL-C testing (n = 29 606) | 0.6 (−0.9 to 2.0) | 2.3 (0.8 to 3.9) |
| LDL-C <100 mg/dL (n = 29 586) | −16.6 (−22.5 to −10.6) | −9.4 (−15.6 to −3.2) |
| Nephropathy screening (n = 31 901) | −5.3 (−7.2 to −3.4) | −6.2 (−8.2 to −4.3) |
| BP control <140/90 mm Hg (n = 24 584) | −2.0 (−8.4 to 4.5) | 0.1 (− 6.6 to 6.8) |
| Cardiovascular care | ||
| LDL-C testing after coronary event (n = 19 848) | −2.4 (−4.9 to 0.1) | 0.9 (−0.9 to 2.7) |
| LDL-C <100 mg/dL after coronary event (n = 19 848) | −27.2 (−39.6 to −14.8) | −13.3 (−20.9 to −5.7) |
| BP control <140/90 mm Hg in hypertension (n = 19 628) | −5.3 (−9.7 to −0.8) | −2.5 (−7.7 to 2.7) |
| β-Blocker treatment after MI (n = 4903) | −9.2 (−12.4 to −6.1) | −8.6 (−13.4 to −3.8) |
| Appropriate drug use | ||
| Receipt of ≥1 high-risk-medication (n = 1 058 260) | 5.2 (−3.9 to 14.2) | 2.7 (−6.3 to 11.7) |
| Use of disease-modifying antirheumatic drug (n = 15 100) | −31.1 (−38.3 to −23.8) | −23.8 (−30.9 to −16.8) |
| Use of systemic corticosteroid in COPD exacerbation (n = 5504) | −23.6 (−27.6 to −19.6) | −21.3 (−27.5 to −15.1) |
| Use of bronchodilator therapy in COPD exacerbation (n = 5504) | −25.0 (−28.9 to −21.1) | −22.7 (−27.7 to −17.6) |
| Cancer screening | ||
| Colorectal (n = 25 834) | 1.7 (−3.9 to 7.4) | 12.5 (5.9 to 19.2) |
| Breast (n = 97 058) | −7.3 (−12.0 to −2.5) | −3.4 (−7.6 to 0.8) |
Abbreviations: BP, blood pressure; COPD, chronic obstructive pulmonary disease; HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; MA, Medicare Advantage; MI, myocardial infarction.
SI conversion factors: To convert HbA1c to a proportion of total Hb, multiply by 0.01; LDL-C to millimoles per liter, multiply by 0.0259.